Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | BUB1 | O43683 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21678293 | 1.00 | MEN1 (0.41) | MEN1ALDH1A1KMT2AAPPBUB1 | |
| SCHEMBL5858618 | 0.87 | — | — | |
| SCHEMBL5858622 | 0.87 | — | — | |
| SCHEMBL21678306 | 0.84 | — | — | |
| SCHEMBL7211354 | 0.82 | NPC1 (0.46) | MEN1ALDH1A1KMT2ABUB1 | |
| SCHEMBL21678294 | 0.79 | KMT2A (0.50) | MEN1ALDH1A1KMT2AAPP | |
| SCHEMBL12521242 | 0.79 | KMT2A (0.50) | MEN1ALDH1A1KMT2AAPP | |
| SCHEMBL13903035 | 0.77 | APP (0.32) | ALDH1A1APP | |
| SCHEMBL7460179 | 0.76 | INSR (0.32) | APPBUB1 | |
| SCHEMBL1234774 | 0.74 | ALDH1A1 (0.49) | MEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3613810-A1 | ARTICLES AND COMPOSITIONS COMPRISING HOST POLYMERS AND CHROMOPHORES AND METHODS OF PRODUCING THE SAME | General Dynamics Mission Systems, Inc. (US) | 2020-02-26 | — | — | EP | disclosed |
| US-20200048428-A1 | ARTICLES AND COMPOSITIONS COMPRISING HOST POLYMERS AND CHROMOPHORES AND METHODS OF PRODUCING THE SAME | GENERAL DYNAMICS MISSION SYSTEMS, INC. | 2020-02-13 | — | — | US | disclosed |
| US-20130123508-A1 | NOVEL NONLINEAR CHROMOPHORES ESPECIALLY SUITED FOR USE IN ELECTRO-OPTICAL MODULATION | ECOLE NORMALE SUPERIEURE DE LYON (FR) | 2013-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130123508-A1 | NOVEL NONLINEAR CHROMOPHORES ESPECIALLY SUITED FOR USE IN ELECTRO-OPTICAL MODULATION | CHRM5, CHRM1, CHRM2 | MEN1 2302/4885ALDH1A1 1272/4885KMT2A 2823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.